These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 277249

  • 1. Prolonged metronidazole administration with protracted radiotherapy: a pilot study on response of advanced tumours.
    Karim AB.
    Br J Cancer Suppl; 1978 Jun; 3():299-301. PubMed ID: 277249
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with misonidazole.
    Dische S, Saunders MI.
    Br J Cancer Suppl; 1978 Jun; 3():311-3. PubMed ID: 277252
    [Abstract] [Full Text] [Related]

  • 3. The optimum regime for the administration of misonidazole and the establishment of multi-centre clinical trials.
    Dische S, Saunders MI, Flockhart IR.
    Br J Cancer Suppl; 1978 Jun; 3():318-21. PubMed ID: 209811
    [Abstract] [Full Text] [Related]

  • 4. Phase I study of hyperfractionated accelerated radiation and simultaneous Carboplatin therapy for advanced head and neck carcinomas.
    Schnabel T, Zamboglou N, Kolotas C, Jiménez W, Strehl H, Schmitt G.
    Strahlenther Onkol; 1992 Jun; 168(6):318-21. PubMed ID: 1621209
    [Abstract] [Full Text] [Related]

  • 5. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N, Pape H, Schnabel T, Wurm R, Bannach B, Fürst G, Schmitt G.
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [Abstract] [Full Text] [Related]

  • 6. [Effectiveness of the radiosensitizer cisplatin. A pilot study].
    Klima A, Szepesi S.
    Laryngol Rhinol Otol (Stuttg); 1987 Sep; 66(9):457-9. PubMed ID: 3683038
    [Abstract] [Full Text] [Related]

  • 7. Dynamic dose-fractionation combined with oxygen breathing at ambient pressure and high-dose metronidazole in head and neck, and uterine cervix cancer.
    Siracká E, Kubovcáková N, Durkovský J, Jancina J, Boljesíková E.
    Neoplasma; 1983 Sep; 30(6):725-31. PubMed ID: 6656969
    [Abstract] [Full Text] [Related]

  • 8. Taxol plus radiation for head and neck cancer.
    Rosenthal DI, Carbone DP.
    J Infus Chemother; 1995 Sep; 5(2):46-54. PubMed ID: 8521234
    [Abstract] [Full Text] [Related]

  • 9. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R.
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [Abstract] [Full Text] [Related]

  • 10. Further clinical experiences of a phase I study with the hypoxic cell radiosensitizer misonidazole.
    Kogelnik HD, Meyer JH, Jentzsch K, Szepesi T, Kärcher KH, Maida E, Mamoli B, Wessely P, Zaunbauer F.
    Br J Cancer Suppl; 1978 Jun; 3():281-5. PubMed ID: 209810
    [Abstract] [Full Text] [Related]

  • 11. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
    Guerrero Urbano T, Clark CH, Hansen VN, Adams EJ, A'Hern R, Miles EA, McNair H, Bidmead M, Warrington AP, Dearnaley DP, Harrington KJ, Nutting CM.
    Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
    [Abstract] [Full Text] [Related]

  • 12. [Chemoradiotherapy for patients with advanced head and neck cancer].
    Tsukuda M.
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W, Hehr T, Budach V, Belka C, Dietz K.
    BMC Cancer; 2006 Jan 31; 6():28. PubMed ID: 16448551
    [Abstract] [Full Text] [Related]

  • 16. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
    Wijffels KI, Marres HA, Peters JP, Rijken PF, van der Kogel AJ, Kaanders JH.
    Oral Oncol; 2008 Apr 31; 44(4):335-44. PubMed ID: 17689286
    [Abstract] [Full Text] [Related]

  • 17. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer.
    Marcial VA, Pajak TF, Kramer S, Davis LW, Stetz J, Laramore GE, Jacobs JR, Al-Sarraf M, Brady LW.
    Semin Oncol; 1988 Feb 31; 15(1):39-60. PubMed ID: 3278390
    [Abstract] [Full Text] [Related]

  • 18. Phase 1 study of high-dose metronidazole: a specific in vivo and in vitro radiosensitizer of hypoxic cells.
    Urtasun RC, Chapman JD, Band P, Rabin HR, Fryer CG, Sturmwind J.
    Radiology; 1975 Oct 31; 117(1):129-33. PubMed ID: 1162051
    [Abstract] [Full Text] [Related]

  • 19. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M, Jaboin J, Taylor R, Wolf J, Banglore M, Van Echo D, Ord R.
    Semin Oncol; 2004 Dec 31; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [Abstract] [Full Text] [Related]

  • 20. Safety of nitroimidazoles.
    Roe FJ.
    Scand J Infect Dis Suppl; 1985 Dec 31; 46():72-81. PubMed ID: 3865353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.